Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Merck (MRK) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
February 1, 2024 6:31 AM ESTMerck (NYSE: MRK) reported Q4 EPS of $0.03, $0.14 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $14.47 billion.
GUIDANCE:
Merck sees FY2024 EPS of $8.44-$8.59, versus the consensus of $8.42. Merck sees... More
